MedPath
HSA Approval

FENOGAL Lidose 200 mg Capsule

SIN11831P

FENOGAL Lidose 200 mg Capsule

FENOGAL Lidose 200 mg Capsule

February 28, 2002

HYPHENS PHARMA PTE. LTD.

HYPHENS PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHYPHENS PHARMA PTE. LTD.
Licence HolderHYPHENS PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

C10AB05

fenofibrate

Manufacturer Information

HYPHENS PHARMA PTE. LTD.

SMB TECHNOLOGY SA

Active Ingredients

FENOFIBRATE

200 mg

Fenofibrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FENOGAL Lidose 200 mg Capsule - HSA Approval | MedPath